| scholarly article | Q13442814 |
| P50 | author | Assiamira Ferrara | Q37637594 |
| Samantha F Ehrlich | Q59161921 | ||
| Laurel A Habel | Q82880626 | ||
| Lori C Sakoda | Q89685276 | ||
| Charles Quesenberry | Q102048181 | ||
| P2093 | author name string | Ninah S Achacoso | |
| Tiffany Peng | |||
| P2860 | cites work | Molecular mechanism of action of metformin: old or new insights? | Q22252798 |
| Metformin and the risk of cancer: time-related biases in observational studies | Q26999266 | ||
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer | Q33556884 | ||
| Understanding the benefit of metformin use in cancer treatment | Q33864199 | ||
| Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders | Q34135248 | ||
| Cohort study of pioglitazone and cancer incidence in patients with diabetes | Q34718437 | ||
| Metformin Prevents Tobacco Carcinogen–Induced Lung Tumorigenesis | Q35333423 | ||
| Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study | Q36013549 | ||
| The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese | Q36031170 | ||
| The effect of metformin and thiazolidinedione use on lung cancer in diabetics | Q36453693 | ||
| The use of metformin and the incidence of lung cancer in patients with type 2 diabetes | Q36477885 | ||
| LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin | Q36630561 | ||
| New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes | Q37319178 | ||
| Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK. | Q37543714 | ||
| Metformin and neoplasia: implications and indications | Q37933592 | ||
| Metformin does not alter the risk of lung cancer: a case-control analysis. | Q38430462 | ||
| First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization | Q41666065 | ||
| Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan | Q44665632 | ||
| Excess costs of medical care for patients with diabetes in a managed care population | Q46399244 | ||
| Ethnic disparities in diabetic complications in an insured population | Q46567646 | ||
| Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth | Q46603046 | ||
| P433 | issue | 2 | |
| P921 | main subject | metformin | Q19484 |
| P304 | page(s) | 174-179 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Cancer Prevention Research | Q2665103 |
| P1476 | title | Metformin use and lung cancer risk in patients with diabetes | |
| P478 | volume | 8 |
| Q38611707 | Drug repurposing in oncology--patient and health systems opportunities. |
| Q37737183 | Effect of Metformin on Different Non-Diabetes Related Conditions, a Special Focus on Malignant Conditions: Review of Literature |
| Q30234587 | Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer? |
| Q38558943 | Expanding the therapeutic spectrum of metformin: from diabetes to cancer. |
| Q35946401 | Glycemic Index, Glycemic Load, and Lung Cancer Risk in Non-Hispanic Whites |
| Q64226496 | Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis |
| Q58699189 | Metformin and blood cancers |
| Q41092838 | Metformin and lung cancer risk in patients with type 2 diabetes mellitus |
| Q36103093 | Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer |
| Q36741232 | Metformin use and young age lung cancer: A case series report |
| Q38774878 | Metformin; a review of its history and future: from lilac to longevity |
| Q52661722 | Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy. |
| Q38728567 | The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development |
| Q38778106 | Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma |
| Q52718768 | Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal. |
| Q92243426 | miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice |
Search more.